These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 26206573)

  • 21. Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis.
    Mallat A; Lotersztajn S
    Am J Physiol Cell Physiol; 2013 Oct; 305(8):C789-99. PubMed ID: 23903700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
    Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
    Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
    Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
    Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of cromolyn sodium as an anti-fibrotic agent targeting both hepatocytes and hepatic stellate cells.
    Choi JS; Kim JK; Yang YJ; Kim Y; Kim P; Park SG; Cho EY; Lee DH; Choi JW
    Pharmacol Res; 2015 Dec; 102():176-83. PubMed ID: 26453959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver fibrosis: from the bench to clinical targets.
    Pinzani M; Rombouts K
    Dig Liver Dis; 2004 Apr; 36(4):231-42. PubMed ID: 15115333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTP1B confers liver fibrosis by regulating the activation of hepatic stellate cells.
    Chen PJ; Cai SP; Yang Y; Li WX; Huang C; Meng XM; Li J
    Toxicol Appl Pharmacol; 2016 Feb; 292():8-18. PubMed ID: 26739621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic stellate cell behavior during resolution of liver injury.
    Iredale JP
    Semin Liver Dis; 2001 Aug; 21(3):427-36. PubMed ID: 11586470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Migration of hepatic stellate cells in fibrotic microenvironment of diseased liver model.
    Chang YZ; Yang L; Yang CQ
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):401-5. PubMed ID: 18693176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts.
    Liang S; Kisseleva T; Brenner DA
    Front Physiol; 2016; 7():17. PubMed ID: 26869935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of the Wnt antagonist Dkk2 links the loss of Sept4 and myofibroblastic transformation of hepatic stellate cells.
    Yanagida A; Iwaisako K; Hatano E; Taura K; Sato F; Narita M; Nagata H; Asechi H; Uemoto S; Kinoshita M
    Biochim Biophys Acta; 2011 Nov; 1812(11):1403-11. PubMed ID: 21763422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct proteomic features of two fibrogenic liver cell populations: hepatic stellate cells and portal myofibroblasts.
    Bosselut N; Housset C; Marcelo P; Rey C; Burmester T; Vinh J; Vaubourdolle M; Cadoret A; Baudin B
    Proteomics; 2010 Mar; 10(5):1017-28. PubMed ID: 20049859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis.
    Baghaei K; Mazhari S; Tokhanbigli S; Parsamanesh G; Alavifard H; Schaafsma D; Ghavami S
    Drug Discov Today; 2022 Apr; 27(4):1044-1061. PubMed ID: 34952225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
    Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
    J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology.
    Mederacke I; Hsu CC; Troeger JS; Huebener P; Mu X; Dapito DH; Pradere JP; Schwabe RF
    Nat Commun; 2013; 4():2823. PubMed ID: 24264436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
    Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
    Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Portal myofibroblasts promote vascular remodeling underlying cirrhosis formation through the release of microparticles.
    Lemoinne S; Cadoret A; Rautou PE; El Mourabit H; Ratziu V; Corpechot C; Rey C; Bosselut N; Barbu V; Wendum D; Feldmann G; Boulanger C; Henegar C; Housset C; Thabut D
    Hepatology; 2015 Mar; 61(3):1041-55. PubMed ID: 25043701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Origin and Fate of Liver Myofibroblasts.
    Kim HY; Sakane S; Eguileor A; Carvalho Gontijo Weber R; Lee W; Liu X; Lam K; Ishizuka K; Rosenthal SB; Diggle K; Brenner DA; Kisseleva T
    Cell Mol Gastroenterol Hepatol; 2024; 17(1):93-106. PubMed ID: 37743012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies to prevent and reverse liver fibrosis in humans and laboratory animals.
    Chen RJ; Wu HH; Wang YJ
    Arch Toxicol; 2015 Oct; 89(10):1727-50. PubMed ID: 25963329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy.
    Cai X; Wang J; Wang J; Zhou Q; Yang B; He Q; Weng Q
    Pharmacol Res; 2020 May; 155():104720. PubMed ID: 32092405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apoptotic and survival signals in hepatic stellate cells.
    Shen H; Fan J; Minuk G; Gong Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 32(5):726-34. PubMed ID: 18007061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.